ENUM .0065 Huge Read Currently, Enumeral has compl
Post# of 4
(Total Views: 187)
Posted On: 10/05/2017 3:03:34 PM
ENUM .0065 Huge Read Currently, Enumeral has completed four collaborations with leading pharmaceutical companies (Sanofi (NYSE:SNY), Crucell (NASDAQ:CRXL), Celgene (NASDAQ:CELG) and Novartis (NYSE:NVS)) and established proof-of-concept data which provided modest cash payments (in the hundreds of thousands of dollars per project). Some of these collaborations have led to additional discussions regarding expanded programs
(0)
(0)Enumeral Biomedical Holdings, Inc. (ENUMQ) Stock Research Links
Scroll down for more posts ▼